Turn Therapeutics Inc (TTRX) Stock Price, Quote & News

Company Profile

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its na...

Industry: Biotechnology

Sector: Healthcare

Phone: 818 546 4011

Website: www.turntherapeutics.com

Address:

250 N Westlake Blvd, Westlake Village, United States

topstockalerts Jun. 1 at 10:59 PM

$TTRX there’s very little to dislike about this setup.

0 · Reply

LewisDaKat Jun. 1 at 7:00 PM

$TTRX Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis https://marketwirenews.com/stock/ttrx/news/turn-therapeutics-reports-interim-analysis-findings--5245075674521612.html?utm_source=stocktwits

0 · Reply

spoppies Jun. 1 at 1:20 PM

$TTRX press release phase 2 of GX-03, at least 90% showed 50% improvement in Eczema. 44% showed 90% improvement. They also noted how quickly it works. Great news for a safe eczema topical. 🔥

1 · Reply

MilsLearning May. 22 at 7:39 PM

$TTRX 🩳🖕🔥

0 · Reply

MilsLearning May. 22 at 9:01 AM

$TTRX

0 · Reply

OfficialStocktwitsUser May. 19 at 2:29 AM

$TTRX RSI: 90.63, MACD: 0.2163 Vol: 0.34, MA20: 3.78, MA50: 3.57 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Dcvfin May. 18 at 6:19 PM

$TTRX missed out on this bump. Still doing my DD so there you go Maybe another dip later on to get in on

0 · Reply

Team_Zissou May. 12 at 2:47 AM

$TTRX https://finance.yahoo.com/ First quarter results are out. Reaffirmed interim in Q2, which is what I’m here for

0 · Reply

spoppies May. 1 at 5:48 PM

$TTRX any news here? Going up.

0 · Reply

BillionerOfKing Apr. 30 at 6:30 PM

$TTRX Current Stock Price: $3.68

0 · Reply

Turn announces interim analysis findings from Phase 2 trial of GX-03

Jun 1, 2026, 8:30 AM EDT - 11 hours ago

Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis

2026-05-27T14:27:57.000Z - 5 days ago

Turn Therapeutics announces peer-reviewed article on GX-03

May 27, 2026, 8:05 AM EDT - 5 days ago

Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model

May 19, 2026, 8:01 AM EDT - 13 days ago

Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026

2026-05-18T12:19:58.000Z - 14 days ago

Turn appoints Hahn as Executive Clinical, Regulatory Lead for GX-03

May 18, 2026, 8:05 AM EDT - 14 days ago

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead

2026-05-11T20:45:49.000Z - 21 days ago

Turn Therapeutics reports Q1 EPS (3c) vs. (1c) last year

May 11, 2026, 4:05 PM EDT - 21 days ago

Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates

May 11, 2026, 4:00 PM EDT - 21 days ago

Turn Therapeutics Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 21 days ago

Turn Therapeutics Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 21 days ago

Turn Therapeutics Slides: Corporate presentation

2026-03-31T20:19:19.000Z - 2 months ago

Turn Therapeutics reports FY25 EPS (12c) vs. (7c) last year

Mar 31, 2026, 4:05 PM EDT - 2 months ago

Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates

Mar 31, 2026, 4:00 PM EDT - 2 months ago

Turn Therapeutics Annual report: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 2 months ago

Turn Therapeutics Earnings release: Q4 2025

2026-03-24T12:12:59.000Z - 2 months ago

Turn Therapeutics secures up to $25M in financing

Mar 24, 2026, 8:00 AM EDT - 2 months ago

Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group

Mar 2, 2026, 1:10 PM EST - 3 months ago

Turn Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 25, 2026, 8:00 AM EST - 3 months ago

Turn Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 17, 2026, 8:00 AM EST - 3 months ago

Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs

Feb 9, 2026, 8:00 AM EST - 4 months ago

Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences

Feb 9, 2026, 7:00 AM EST - 4 months ago

Turn Therapeutics Slides: Corporate presentation

Jan 12, 2026, 8:05 AM EST - 5 months ago

Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 4:05 PM EST - 5 months ago

Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors

Jan 7, 2026, 7:00 AM EST - 5 months ago

Turn Therapeutics Slides: Corporate presentation

2025-12-29T12:10:48.000Z - 5 months ago

Turn Therapeutics initiated with a Buy at D. Boral Capital

2025-11-13T13:11:36.000Z - 7 months ago

Turn Therapeutics reports Q3 EPS (7c) vs (3c) last year

Nov 13, 2025, 8:00 AM EST - 7 months ago

Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Nov 13, 2025, 7:00 AM EST - 7 months ago

Turn Therapeutics Quarterly report: Q3 2025

Nov 13, 2025, 7:00 AM EST - 7 months ago

Turn Therapeutics Earnings release: Q3 2025

Nov 11, 2025, 4:05 PM EST - 7 months ago

Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.

Nov 11, 2025, 8:00 AM EST - 7 months ago

Turn Therapeutics' GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine

Nov 4, 2025, 5:07 PM EST - 7 months ago

Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications

2025-10-30T11:42:31.000Z - 7 months ago

Turn Therapeutics enters global supply, license agreement with Medline

Oct 30, 2025, 7:30 AM EDT - 7 months ago

Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline

2025-10-22T12:05:58.000Z - 7 months ago

Turn Therapeutics provides shareholder update on clinical program progress

Oct 22, 2025, 8:00 AM EDT - 7 months ago

Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones

2025-10-20T12:31:05.000Z - 8 months ago

Turn Therapeutics launches webinar series for shareholder engagement

Oct 20, 2025, 8:22 AM EDT - 8 months ago

Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025

2025-10-15T12:11:25.000Z - 8 months ago

Turn Therapeutics appoints Kester to board of directors

Oct 14, 2025, 12:07 PM EDT - 8 months ago

Turn Therapeutics Appoints Arthur Golden to Board of Directors

2025-10-09T20:20:28.000Z - 8 months ago

Turn Therapeutics files to sell 7M shares off common stock for holders

2025-10-09T13:50:11.000Z - 8 months ago

Turn Therapeutics Inc. Common Stock trading resumes

2025-10-09T13:45:18.000Z - 8 months ago

Turn Therapeutics Inc. Common Stock trading halted, volatility trading pause

Oct 9, 2025, 8:00 AM EDT - 8 months ago

Turn Therapeutics Registration statement: Registration Filing

2025-10-09T09:05:25.000Z - 8 months ago

Turn Therapeutics commences trading on Nasdaq

Sep 29, 2025, 10:02 AM EDT - 8 months ago

Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market

topstockalerts Jun. 1 at 10:59 PM

$TTRX there’s very little to dislike about this setup.

0 · Reply

LewisDaKat Jun. 1 at 7:00 PM

0 · Reply

spoppies Jun. 1 at 1:20 PM

$TTRX press release phase 2 of GX-03, at least 90% showed 50% improvement in Eczema. 44% showed 90% improvement. They also noted how quickly it works. Great news for a safe eczema topical. 🔥

1 · Reply

MilsLearning May. 22 at 7:39 PM

$TTRX 🩳🖕🔥

0 · Reply

MilsLearning May. 22 at 9:01 AM

$TTRX

0 · Reply

OfficialStocktwitsUser May. 19 at 2:29 AM

0 · Reply

Dcvfin May. 18 at 6:19 PM

$TTRX missed out on this bump. Still doing my DD so there you go Maybe another dip later on to get in on

0 · Reply

Team_Zissou May. 12 at 2:47 AM

$TTRX https://finance.yahoo.com/ First quarter results are out. Reaffirmed interim in Q2, which is what I’m here for

0 · Reply

spoppies May. 1 at 5:48 PM

$TTRX any news here? Going up.

0 · Reply

BillionerOfKing Apr. 30 at 6:30 PM

$TTRX Current Stock Price: $3.68

0 · Reply

DwigtMcDichael Apr. 3 at 2:10 AM

$TTRX @E_Ltrade we’ll see Cautiously 👇

0 · Reply

E_Ltrade Mar. 26 at 10:01 AM

$TTRX Pending news in the next 2 weeks after the $25MIL financing. Non dilutive until 2027. Get in now before the PR

1 · Reply

Tango_Charlie_Lima Mar. 24 at 1:05 PM

$TTRX $25 Million in Financing From Avenue Capital Group https://ir.turntherapeutics.com/news-releases/news-release-details/turn-therapeutics-secures-25-million-financing-avenue-capital

1 · Reply

DwigtMcDichael Feb. 27 at 8:44 PM

$TTRX 6% of port today after the drop. Easiest buy this year* *buyout within the year imo

0 · Reply

E_Ltrade Feb. 24 at 2:04 AM

$TTRX conference today. Revealing more GX-03.. on watch list

0 · Reply

spoppies Feb. 9 at 10:19 PM

$TTRX meeting with institutional investors https://ir.turntherapeutics.com/news-releases/news-release-details/turn-therapeutics-present-upcoming-td-cowen-and-oppenheimer

1 · Reply

BillionerOfKing Feb. 7 at 1:57 AM

$TTRX Current Stock Price: $3.87

0 · Reply

KUMO2026 Jan. 14 at 4:53 PM

$TTRX swing trade here

0 · Reply

joedoe007 Jan. 14 at 1:50 PM

$ROLR Can someone confirm that this is not simply a pump n dump ticker that is getting pumped to high heavens in premarket ONLY to be dumped hard after open and for days and weeks without the chance of a PUmp 2.0 again Ju know like we saw with $TTRX pump n dump 3 months ago.

2 · Reply

joedoe007 Jan. 12 at 10:30 PM

$EVTV They will fade this ticker down hard just like they did after the Sep 12 spike to $4 and the subsequent crash to 47 cents Thats the game wall street plays with us innocent shareholders They rally a stock for no reason to $4 and then just when everyone is bullish and jumping w joy, they crash it to 47 cents they did that kind of pump n dump move even worse to $PTHL and $TTRX

1 · Reply

3luxx Jan. 12 at 3:55 PM

$TTRX give me $10 🤑 $HIMS $NVDA $NFLX $META

0 · Reply

cashcow1 Dec. 30 at 8:05 PM

$TTRX adding few hundreds here.

1 · Reply

Market Cap	154.90M
Revenue (ttm)	0.00
Net Income (ttm)	-3.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.97

Volume	268,800
Avg Vol	32,870
Day's Range	N/A - N/A
Shares Out	29.79M
Stochastic %K	80%
Beta	N/A
Analysts	Strong Buy
Price Target	$8.00